PATSY HUDSON: Open Payments
NPI 1902316607 · HANNIBAL, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$435 in 25 payments from 15 companies in 2025. Trend: 2023 $158 · 2024 $190 · 2025 $435
Food & beverage: $435
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $64 |
| Corcept Therapeutics | 2 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $46 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $40 |
| GlaxoSmithKline, LLC. | 2 | $33 |
| Amgen Inc. | 2 | $30 |
| Novo Nordisk Inc | 2 | $28 |
| Boston Scientific Corporation | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Dexcom, Inc. | 1 | $20 |
Products named: Korlym, VRAYLAR, CAPLYTA, JOURNAVX, WATCHMAN Access System, BREZTRI, Dexcom G6 Transmitter, ZEPBOUND.
Industry payments across MO — which companies pay providers there.
